ILiAD Biotechnologies
LightNews LightNews
banner
iliadbio.bsky.social
ILiAD Biotechnologies
@iliadbio.bsky.social
1 followers 5 following 5 posts
ILiAD Biotechnologies is advancing the next generation pertussis vaccine for the prevention of whooping cough.
Posts Replies Media Videos
iliadbio.bsky.social
This RA Capital Management article is a must read.

#whoopingcough #pertussis #biotech #vaccines #innovation #racapital
static1.squarespace.com
February 28, 2025 at 8:26 PM
iliadbio.bsky.social
In light of rising whooping cough rates, we continue to press forward with our lead candidate BPZE1, the most advanced next-gen pertussis vaccine in development. 1/2
U.S. records most whooping cough deaths since 2017
Pertussis cases are on the rise again, after a dip following the winter holidays.
www.cbsnews.com
February 15, 2025 at 4:56 PM
iliadbio.bsky.social
The ILiAD team is proud to be nominated for the Best Prophylactic Vaccine Award by the Vaccine Industry Excellence Awards in DC. Voting is open terrapinn-awards.evessiocloud.com/vieawards202.... Please feel free to share.

#whoopingcough #pertussis #biotech #vaccines #innovation
ViE Awards 2025 - Vaccine Industry Excellence
Vaccine Industry Excellence - Showcasing excellence in the global vaccine industry
terrapinn-awards.evessiocloud.com
February 3, 2025 at 3:22 PM
iliadbio.bsky.social
We are pleased to announce that we have signed a Letter of Intent with hVIVO for a pivotal phase 3 trial of BPZE1 pertussis vaccine following an FDA meeting.
 
www.businesswire.com/news/home/20...
 
#whoopingcough #pertussis #biotech #vaccines #innovation
ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting
ILiAD Biotechnologies, LLC, a biotech company developing BPZE1, the most advanced next generation intranasal pertussis vaccine to protect against whoo
www.businesswire.com
January 27, 2025 at 1:02 PM